Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 792187, 9 pages
http://dx.doi.org/10.1155/2015/792187
Review Article

B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia

1Department of Pediatric Oncology, University Hospital and Faculty of Medicine, Masaryk University, Cernopolni 9, 613 00 Brno, Czech Republic
2Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 53 Brno, Czech Republic
3Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
4Advanced Cell Immunotherapy Unit, Department of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic

Received 22 October 2014; Accepted 28 April 2015

Academic Editor: Olive Joy Wolfe

Copyright © 2015 Michal Rihacek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Vasiliki Pelekanou, George Notas, Paraskevi Athanasouli, Konstantinos Alexakis, Fotini Kiagiadaki, Nikolaos Peroulis, Konstantina Kalyvianaki, Errika Kampouri, Hara Polioudaki, Panayiotis Theodoropoulos, Andreas Tsapis, Elias Castanas, and Marilena Kampa. View at Publisher · View at Google Scholar
  • Jing-Zhang Wang, Yu-Hua Zhang, Xin-Hua Guo, Hong-Yan Zhang, and Yuan Zhang, “The double-edge role of B cells in mediating antitumor T-cell immunity: Pharmacological strategies for cancer immunotherapy,” International Immunopharmacology, vol. 36, pp. 73–85, 2016. View at Publisher · View at Google Scholar
  • Hiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, Kyohei Kishino, Yoshihiro Shimono, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Takashi Nishimura, Kazunori Yoh, Akio Ishii, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Hiroko Iijima, and Shuhei Nishiguchi, “B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-gamma-Inducible Protein-10 in Autoimmune Hepatitis,” Medicine, vol. 95, no. 12, 2016. View at Publisher · View at Google Scholar
  • Iole Maria Di Gangi, Urska Vrhovsek, Valerio Pazienza, Tommaso Mazza, Andrea Fontana, Massimiliano Copetti, Caterina Fusilli, Antonio Ippolito, Fulvio Mattivi, Anna Latiano, and Angelo Andriulli, “Metabolomic profile in pancreatic cancer patients: A consensusbased approach to identify highly discriminating metabolites,” Oncotarget, vol. 7, no. 5, pp. 5815–5829, 2016. View at Publisher · View at Google Scholar
  • Jonathan P GroΔ, Jens Hillengass, Maximilian Merz, Johanna Nattenmüller, Stefan Hemmer, Diana Tichy, Julia Krzykalla, Hartmut Goldschmidt, Uta Bertsch, Stefan Delorme, and Hans-Ulrich Kauczor, “Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trial.,” Oncotarget, vol. 8, no. 40, pp. 68460–68471, 2017. View at Publisher · View at Google Scholar
  • Brenda M. Birmann, Bernard Rosner, Julie L. Batista, Edward L. Giovannucci, Larry Magpantay, Jon C. Aster, Scott J. Rodig, Mara M. Epstein, Francine Laden, Otoniel Martínez-Maza, Elizabeth C. Breen, and Kimberly A. Bertrand, “Pre-diagnosis plasma immune markers and risk of non-hodgkin lymphoma in two prospective cohort studies,” Haematologica, vol. 103, no. 10, pp. 1679–1687, 2018. View at Publisher · View at Google Scholar
  • Vasiliki Pelekanou, George Notas, Paraskevi Athanasouli, Konstantinos Alexakis, Fotini Kiagiadaki, Nikolaos Peroulis, Konstantina Kalyvianaki, Errika Kampouri, Hara Polioudaki, Panayiotis Theodoropoulos, Andreas Tsapis, Elias Castanas, and Marilena Kampa, “BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness,” Frontiers in Oncology, vol. 8, 2018. View at Publisher · View at Google Scholar
  • Juan F. Santibanez, and Suncica Bjelica, “Novel patents targeting interleukin-17A; implications in cancer and inflammation,” Recent Patents on Anti-Cancer Drug Discovery, vol. 13, no. 2, pp. 133–144, 2018. View at Publisher · View at Google Scholar
  • Franco Grimaldi, Veronica Tonelli, Cinzia Pistis, Francesco Curcio, Fabio Vescini, Elda Kara, Vincenzo Triggiani, Elio Tonutti, and Martina Fabris, “Exploring the possible prognostic role of B-Lymphocyte stimulator (BLys) in a large series of patients with neuroendocrine tumors,” Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 18, no. 6, pp. 618–625, 2018. View at Publisher · View at Google Scholar
  • Foteinos-Ioannis D. Dimitrakopoulos, Anastasia E. Kottorou, Anna G. Antonacopoulou, Nikolaos Panagopoulos, Chrisoula Scopa, Melpomeni Kalofonou, Dimitrios Dougenis, Angelos Koutras, Thomas Makatsoris, Vassiliki Tzelepi, and Haralabos P. Kalofonos, “Expression of Immune System-Related Membrane Receptors CD40, RANK, BAFFR and LTβR is Associated with Clinical Outcome of Operated Non-Small-Cell Lung Cancer Patients,” Journal of Clinical Medicine, vol. 8, no. 5, pp. 741, 2019. View at Publisher · View at Google Scholar
  • Mahmoud T. Abo-Elfadl, Amira M. Gamal-Eldeen, Manal F. Ismail, and Nancy N. Shahin, “Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer,” Cytokine, vol. 125, pp. 154790, 2020. View at Publisher · View at Google Scholar